[ad_1]
The Joint Committee on Vaccination and Immunization (JCVI) has stated that it will follow a “precautionary course” for people 30 to 39 years after assessing the risk of blood clots.
According to the committee’s professor, Wei Shen Limo, 30-39-year-olds “will first be offered an alternative to AstraZeneca.”
This will last until an alternative vaccine is available, until such distribution significantly delays the vaccination campaign and until the UK controls its epidemiological situation, he said.
According to the professor, the goal is to “further increase confidence in the vaccine” by showing that “safety is an important priority” for the government, as vaccination of people under 40 should start soon.
The UK, which launched a vaccination campaign with the Pfizer-BioNTech vaccine last December, has so far not given up its goal of vaccinating the entire adult population with the first dose by the end of July, Sh said. Limes
According to him, a successful vaccination means that “the wave of infection is likely to be less in the future than was currently thought.”
At the time, June Raine, director of the Agency for Medicines and Healthcare (MHRA), said the agency would not change its recommendation for the AstraZeneca vaccine because side effects were “extremely rare.”
Of the more than 28 million. 242 rare cases of blood clots, or 10.5 cases per million vaccinated people, were reported in the first doses given in the UK before April 28, it said.
Six similar side effects were reported after the second dose of the vaccine.
According to Raine, this means that the benefits of AstraZeneca still outweigh any risks for the vast majority of people.
In the UK, nearly 128,000 people died from the coronavirus. people, mainly throughout Europe.
Now there are 35 million in Britain. population has received the first dose of the vaccine and more than 16 million – both doses.
A government spokesman said the government would listen to the recommendations.
“The Oxford and AstraZeneca vaccines are safe, effective and have saved thousands of lives in the UK and around the world,” he said.
“More than 50 million have already been used. The vaccine doses, the current vaccine supply and the level of infection allow us to take this precautionary step, without abandoning the goal of offering the vaccine to all adults by the end of July.” said a government spokesman.
It is not allowed to publish, quote or reproduce the information of the BNS news agency in the media and on websites without the written consent of the UAB “BNS”.
[ad_2]
